Streetbeat News

Regulatory

BTCUSD

DOGEUSD

ETHUSD

Bitcoin, Ethereum, and Dogecoin remained largely flat on Tuesday as the global cryptocurrency market cap rose slightly by 0.4% to $1.04 trillion. The Financial Accounting Standards Board (FASB) has unanimously decided to endorse regulations for the accounting of fair values associated with companies’ cryptocurrency holdings, effective from 2025. Meanwhile, the dollar index rose to 104.84, unnerving investors. Cryptocurrency trader Michaël van de Poppe advised investors to 'just survive this month' and predicted a positive outlook for Bitcoin and Ethereum.

Portfolio Pulse from Shivdeep Dhaliwal

September 07, 2023 | 2:51 am

DOGEUSD

GOOG

MSFT

Elon Musk and Dogecoin co-creator Billy Markus have criticized Alphabet Inc.'s YouTube's decision to strip creators of some ad control options. YouTube plans to eliminate individual ad controls for pre-roll, post-roll, skippable, and non-skippable ads on new videos. Instead, creators will have a binary choice: ads before or after a video, with YouTube determining the type of ad to display. The decision has been met with backlash on social media, including Musk's X, formerly Twitter.

Portfolio Pulse from Ananya Gairola

September 07, 2023 | 2:13 am

AAPL

AMC

GME

PFE

TSLA

US stocks experienced a downward trend with Dow Jones declining by 0.57% and NASDAQ by 1.06%. The stocks that gained attention were GameStop, Apple, Pfizer, Tesla, and AMC. GameStop shares declined by 2.50% despite a Q2 net sales increase of 2.5%. Apple's shares decreased by 3.58% following China's ban on iPhones for government officials. Pfizer's stock declined by 2.85% after UK regulators approved an updated COVID-19 vaccine. Tesla shares dropped by 1.78% despite a 9.4% YoY increase in China sales. AMC shares plummeted by 36.80% after announcing an agreement to sell up to 40 million shares.

Portfolio Pulse from Benzinga Neuro

September 07, 2023 | 1:45 am

ACRHF

CURLF

GTBIF

In August, Maryland's collective adult-use and medical cannabis purchases reached $91.7 million, surpassing the previous month's total of $87.4 million. This increase in sales is attributed to the state's decision to legalize adult-use cannabis and implement a hybrid licensing structure. Four prominent medical marijuana companies, Curaleaf Holdings, Green Thumb Industries, Acreage Holdings, and PharmaCann, have urged New York Gov. Hochul to adopt a similar licensing structure.

Portfolio Pulse from Maureen Meehan

September 06, 2023 | 11:41 pm

FOX

FOXA

RUM

Former President Donald Trump continues to dominate election polls for the 2024 GOP nomination, with a recent poll showing a 45-point lead. Despite skipping the first Republican primary debate and facing multiple indictments, Trump's support remains strong. The poll also showed a drop in support for biotech entrepreneur Vivek Ramaswamy, while Ron DeSantis and Nikki Haley maintained their positions. The second Republican primary debate will be aired on Fox Corporation's Fox Business and livestreamed on Rumble Inc.

Portfolio Pulse from Chris Katje

September 06, 2023 | 11:22 pm

BMY

PFE

Shares of Pfizer Inc. (PFE) are trading near their 52-week low due to concerns over President Joe Biden’s Inflation Reduction Act, which allows Medicare to negotiate the price of some prescription drugs. However, Cantor Fitzgerald analyst Louise Chen believes the impact of the act on Pfizer's drugs will not be significant in the short term. She reiterated an Overweight rating on Pfizer with a $75 price target, indicating a potential 117.99% upside for the stock. Bristol-Myers Squibb Co (BMY) is also mentioned as they co-sell a drug with Pfizer that is on the negotiation list.

Portfolio Pulse from AJ Fabino

September 06, 2023 | 10:37 pm

ARKK

ETHUSD

Ark Invest, in collaboration with 21Shares, has submitted a proposal to the SEC for an Ethereum-based ETF named ARK 21Shares Ethereum ETF. The ETF aims to offer investors direct access to Ethereum and will be listed on the Cboe BZX Exchange. The SEC's approval for this ETF is still pending.

Portfolio Pulse from Murtuza Merchant

September 06, 2023 | 10:25 pm

SMTC

Semtech Corporation has filed a notification of late filing on Form 12b-25, stating that its goodwill impairment assessment is not yet complete. The company plans to file its Q2 Form 10-Q with the SEC as soon as possible, but no later than September 13, 2023. Additionally, Semtech will reschedule its earnings release and investor conference call for Q2 of fiscal year 2024, which was initially scheduled for September 7, 2023.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 9:50 pm

ITA

LMT

NOC

XAR

The U.S. Department of Defense is planning to develop a fleet of autonomous, unmanned vehicles that use artificial intelligence for defense tasks. The project, named 'Replicator', is expected to produce thousands of fully autonomous units within 18 to 24 months. The department aims to speed up the development of AI-powered military instruments to compete with China's fast innovation in the field. The defense sector had a negative day in Wall Street, with shares from Lockheed Martin Corp, Boeing Co, Northrop Grumman Corp, iShares US Aerospace & Defense ETF, and SPDR S&P Aerospace & Defense ETF all dropping.

Portfolio Pulse from Natan Ponieman

September 06, 2023 | 9:35 pm

AWKNF

Awakn Life Sciences Corp. (OTC:AWKNF) has submitted a Clinical Trial Application (CTA) for a phase III clinical trial for its leading program, AWKN-P001, designed for the treatment of Severe Alcohol Use Disorder (SAUD). The trial will be conducted at ten UK National Health Service (NHS) sites and will involve 280 participants. The company expects to receive feedback on the CTA in the coming months and aims to commence treatment in late Q4 2023 or early Q1 2024.

Portfolio Pulse from The Dales Report

September 06, 2023 | 9:27 pm